This inventor holds 1 USPTO granted patent. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Bo T Lungren: Innovator in Pharmaceutical Compounds
Introduction
Bo T Lungren is a notable inventor based in Frillesas, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating acute myocardial infarction. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Lungren holds a patent for a compound described as Substituted 3-phenoxy-1-alkoxycarbonylalkylamino-propanol-2-s. This invention relates to new compounds that possess beta-adrenoceptor blocking activity. These compounds are characterized by their short-acting properties and are intended for treatment through injection, specifically targeting acute myocardial infarction.
Career Highlights
Lungren is associated with E.I. DuPont De Nemours and Company, where he has contributed to various research initiatives. His work has been instrumental in advancing pharmaceutical preparations that can improve patient outcomes in critical medical situations.
Collaborations
Throughout his career, Lungren has collaborated with esteemed colleagues, including Enar I Carlsson and Bill B Gustafsson. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Bo T Lungren's contributions to the field of pharmaceuticals highlight the importance of innovation in developing life-saving treatments. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile